HeyJaredMayo Clinic
- Indexed articles, last 90 days
- 24
- Latest publication
- Sep 28, 2026
- Outlet visibility, for Newswise
- Top 1M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Study Finds Fractionated Radiosurgery Reduces Recurrence After Surgery for Brain Metastases, May Improve Survival | Newswise (opens the original)
Read excerpt
Dr. Paul D. Brown discusses a brain scan displayed on a computer monitor with a patient during a consultation. Newswise — ROCHESTER, Minn. — Mayo Clinic researchers led a multicenter study that found dividing radiation into several treatments, known as fractionated stereotactic radiosurgery, reduced the risk of cancer returning after surgery for brain metastases and was associated with improved survival compared with delivering radiation in a single treatment. The findings are being presented to
Mayo Clinic Experts Present Radiation Oncology Research at ASTRO 2026 | Newswise (opens the original)
Read excerpt
Newswise — ROCHESTER, Minn. — Mayo Clinic researchers will present findings on emerging technologies, precision treatments and new radiation therapy techniques at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 26–30 in Boston. Mayo Clinic experts will participate in nearly 65 poster, education, quick-pitch, scientific, oral, plenary and presidential sessions and present 45 abstracts. Their presentations will cover topics ranging from artificial intelligence (AI) a
Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study | Newswise (opens the original)
Read excerpt
Newswise — ROCHESTER, Minn. — A large prospective study published today in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests. Mayo Clinic was among the institutions participating in the prospective, interventional study, which enrolled 35,878 adults age 50 and older. Karthik Giridhar, M.D., a Mayo Clinic med
Study Shows Reprogramming Thyroid Tumors May Improve CAR-T Cell Therapy | Newswise (opens the original)
Read excerpt
Newswise — ROCHESTER, Minn. — Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can change in ways that allow them to hide from immune cells designed to attack them. In a preclinical study published in Molecular Cancer, researchers found that drugs used to treat advanced thyroid cancer can restore a marker on aggressive thyroid cancer cells, making the
Mayo Clinic and Thermo Fisher Scientific Launch Precure, LLC to Identify Signs of Disease Before Symptoms Appear | Newswise (opens the original)
Read excerpt
Newswise — ROCHESTER, Minn. and WALTHAM, Mass. — Mayo Clinic today announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, the world leader in serving science, to help transform how the life sciences community understands the biological changes that occur as people move from health toward disease. Precure, LLC will create one of the world’s leading biomedical datasets through one of the largest human multi-omics data-generation efforts, integrating proteomic, genomi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For Newswise, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.